Pharyngeal electrical stimulation for neurogenic dysphagia (IPG781)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 January 2024
SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 9 July 2024
Sirolimus for treating angiofibroma from tuberous sclerosis complex in people 6 years and older [ID3990]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 18 September 2024
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitisStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: 5 February 2025
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps TS ID 11918Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over TS ID 11936Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Depemokimab for treating chronic rhinosinusitis with nasal polyps TSID 12012Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC